Two Sigma Securities’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4K | Buy |
+18,028
| New | +$16.4K | ﹤0.01% | 1241 |
|
|
2024
Q4 | – | Sell |
-13,941
| Closed | -$12.6K | – | 1884 |
|
|
2024
Q3 | $12.6K | Buy |
+13,941
| New | +$12.6K | ﹤0.01% | 1313 |
|
|
2024
Q1 | – | Sell |
-12,704
| Closed | -$13.8K | – | 1823 |
|
|
2023
Q4 | $13.8K | Buy |
+12,704
| New | +$13.8K | ﹤0.01% | 1212 |
|
|
2023
Q2 | – | Sell |
-16,538
| Closed | -$24.8K | – | 1619 |
|
|
2023
Q1 | $24.8K | Sell |
16,538
-782
| -5% | -$1.17K | ﹤0.01% | 1039 |
|
|
2022
Q4 | $20.3K | Buy |
+17,320
| New | +$20.3K | ﹤0.01% | 1069 |
|
|
2021
Q4 | – | Sell |
-96,762
| Closed | -$244K | – | 1247 |
|
|
2021
Q3 | $244K | Buy |
+96,762
| New | +$244K | 0.01% | 475 |
|
|
2018
Q4 | – | Sell |
-14,906
| Closed | -$31K | – | 1463 |
|
|
2018
Q3 | $31K | Buy |
+14,906
| New | +$31K | ﹤0.01% | 1024 |
|